Advances in Clinical Chemistry, Volume 71, is the latest installment in this internationally acclaimed series. This latest volume contains chapters authored by world-renowned clinical laboratory scientists, physicians, and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry and is the benchmark for novel analytical approaches in the clinical laboratory.
Advances in Clinical Chemistry, Volume 71, is the latest installment in this internationally acclaimed series. This latest volume contains chapters authored by world-renowned clinical laboratory scientists, physicians, and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry and is the benchmark for novel analytical approaches in the clinical laboratory.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Inhaltsangabe
Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
Michael J. Duffy, Siun Walsh, Enda W. McDermott and John Crown
Polycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA
Ioana R. Ilie and Carmen E. Georgescu
EN2 in Prostate Cancer
Sophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.
Cytochrome P450 in Cancer Susceptibility and Treatment